{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:28:33Z","timestamp":1778941713310,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":433,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.bbmt.2013.11.006","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T18:27:11Z","timestamp":1384280831000},"page":"149-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Blood and Marrow Transplant Clinical Trials Network: Progress since the State of the Science Symposium 2007"],"prefix":"10.1016","volume":"20","author":[{"given":"James L.M.","family":"Ferrara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.11.006_bib1","first-page":"1072","article-title":"Thymic immunopathology after cyclosporine: effect of irradiation and age on medullary involution and recovery","volume":"20","author":"Beschorner","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2013.11.006_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00007890-199007000-00020","article-title":"The thymus and prolonged administration of cyclosporine","volume":"50","author":"Shinozawa","year":"1990","journal-title":"Transplant"},{"key":"10.1016\/j.bbmt.2013.11.006_bib3","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1182\/blood.V98.13.3868","article-title":"Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial","volume":"98","author":"Kansu","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00007890-198801000-00043","article-title":"Transfer of cyclosporine-associated syngeneic graft-versus-host disease by thymocytes. Resemblance to chronic graft-versus-host disease","volume":"45","author":"Beschorner","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.11.006_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-065X.1985.tb01158.x","article-title":"Graft-versus-host reactions and disease","volume":"88","author":"Santos","year":"1985","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2013.11.006_bib6","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood-2006-08-044529","article-title":"In\u00a0vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation","volume":"109","author":"Nguyen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-3959(95)00039-U","article-title":"Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial","volume":"63","author":"Syrjala","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.bbmt.2013.11.006_bib8","first-page":"1157","article-title":"An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation","volume":"18","author":"Dimeo","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.006_bib9","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V90.9.3390","article-title":"Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy","volume":"90","author":"Dimeo","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib10","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2273::AID-CNCR24>3.0.CO;2-B","article-title":"Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy","volume":"85","author":"Dimeo","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2013.11.006_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.bmt.1704378","article-title":"Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate-intensity, exercise program","volume":"33","author":"Hayes","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.006_bib12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.bmt.1704815","article-title":"Pilot study of a home-based aerobic exercise program for sedentary cancer survivors treated with hematopoietic stem cell transplantation","volume":"35","author":"Wilson","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.006_bib13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.bmt.1705343","article-title":"Individualized exercise program for the treatment of severe fatigue in patients after allogeneic hematopoietic stem-cell transplant: a pilot study","volume":"37","author":"Carlson","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.006_bib14","unstructured":"Pasquini MC. CIBMTR Summary Slides Part 1. 2005;Slides Part\u00a01."},{"key":"10.1016\/j.bbmt.2013.11.006_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0025-6196(11)61029-X","article-title":"Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement","volume":"82","author":"Dispenzieri","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bbmt.2013.11.006_bib16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/cncr.20945","article-title":"Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis","volume":"103","author":"Yanada","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2013.11.006_bib17","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood-2006-06-025627","article-title":"Results of a HOVON\/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?","volume":"109","author":"Cornelissen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood-2006-10-043299","article-title":"Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission","volume":"110","author":"Tallman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2005.03.2177","article-title":"High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group","volume":"24","author":"Yanada","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2013.11.006_bib20","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","article-title":"Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate","volume":"103","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib21","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2006-03-011908","article-title":"Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study","volume":"109","author":"de Labarthe","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/asheducation-2006.1.279","article-title":"New prognostic markers in CLL","author":"Montserrat","year":"2006","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.bbmt.2013.11.006_bib23","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2005.04.569","article-title":"Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia","volume":"23","author":"Sorror","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2013.11.006_bib24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","article-title":"T-cell non-Hodgkin lymphoma","volume":"107","author":"Rizvi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.all.0000246626.57118.d9","article-title":"Hemophagocytic lymphohistiocytosis and related disorders","volume":"6","author":"Filipovich","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2013.11.006_bib26","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood-2005-05-1819","article-title":"Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis","volume":"107","author":"Cooper","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V108.11.174.174","article-title":"Unrelated donor hematopoietic cell transplant (HCT) for hemophagocytic lymphohistiocytosis (HLH)","volume":"108","author":"Baker","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib28","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2002-12-3908","article-title":"High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis","volume":"102","author":"Nash","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2141.2004.05298.x","article-title":"Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective","volume":"128","author":"Hough","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.11.006_bib30","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2004.11.051","article-title":"Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease","volume":"128","author":"Oyama","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbmt.2013.11.006_bib32","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.3748\/wjg.v12.i41.6665","article-title":"Hematopoietic cell transplantation for Crohn's disease: is it time?","volume":"12","author":"Leung","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bbmt.2013.11.006_bib33","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2013.11.006_bib34","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-02-001909","article-title":"Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation","volume":"108","author":"Amrolia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib35","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2005-01-0393","article-title":"Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation","volume":"106","author":"Solomon","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.006_bib37","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113005259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113005259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:45:51Z","timestamp":1761057951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113005259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1083879113005259"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.006","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood and Marrow Transplant Clinical Trials Network: Progress since the State of the Science Symposium 2007","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}